AdAlta Limited, a clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye... AdAlta Limited, a clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. It has discovered WD-34 for the multiple malaria species, Babesia, and Toxoplasma in collaboration with La Trobe University. The company was incorporated in 2006 and is based in Camberwell, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.001 | 100 | 0.001 | 0.002 | 0.001 | 472000 | 0.00194162 | DE |
| 4 | 0.001 | 100 | 0.001 | 0.002 | 0.001 | 789128 | 0.00133793 | DE |
| 12 | 0 | 0 | 0.002 | 0.003 | 0.001 | 2275741 | 0.00231821 | DE |
| 26 | 0 | 0 | 0.002 | 0.004 | 0.001 | 7853189 | 0.00235479 | DE |
| 52 | 0.001 | 100 | 0.001 | 0.004 | 0.001 | 5800628 | 0.00224864 | DE |
| 156 | 0 | 0 | 0.002 | 0.004 | 0.001 | 5447803 | 0.00223782 | DE |
| 260 | 0 | 0 | 0.002 | 0.004 | 0.001 | 5447803 | 0.00223782 | DE |
jxyzobrien
22分前
eagle8
24分前
Mrs kronwell
26分前
superman2026
27分前
gregcod
35分前
t1215s
38分前
gregcod
53分前
sage007
56分前
FlashySage44
1時間前
ulmadi
1時間前
Methinks
2時間前
EZ2
2時間前
t1215s
2時間前
Golfnut3
2時間前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。